CEL-SCI CORPORATION Earnings Per Share (Diluted)
CEL-SCI CORPORATION (CVM) reported Earnings Per Share (Diluted) of -$0.47 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-14
- CEL-SCI CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was -$0.47.
- CEL-SCI CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was -$0.67.
- CEL-SCI CORPORATION earnings per share, diluted for the quarter ending 2025-12-31 was -$0.68.
- CEL-SCI CORPORATION earnings per share, diluted for the quarter ending 2025-06-30 was -$1.36.
- CEL-SCI CORPORATION earnings per share, diluted for fiscal 2025 was -$6.27.
- CEL-SCI CORPORATION earnings per share, diluted for fiscal 2024 was -$15.31.
- CEL-SCI CORPORATION earnings per share, diluted for fiscal 2023 was -$0.73.
- CEL-SCI CORPORATION earnings per share, diluted for fiscal 2022 was -$0.87.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.47 10-Q · filed 2026-08-14 | -$1.76 10-Q · filed 2026-08-14 | ||||||
| 2026-03-31 | -$0.67 10-Q · filed 2026-05-15 | -$1.35 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$0.68 10-Q · filed 2026-02-17 | |||||||
| 2025-09-30 | -$6.27 10-K · filed 2025-12-29 | |||||||
| 2025-06-30 | -$1.36 10-Q · filed 2026-08-14 | -$6.34 10-Q · filed 2026-08-14 | ||||||
| 2025-03-31 | -$2.33 10-Q · filed 2026-05-15 | -$0.08 10-Q · filed 2025-05-14 | -$5.47 10-Q · filed 2026-05-15 | -$0.18 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | -$3.25 10-Q · filed 2026-02-17 | -$0.11 10-Q · filed 2025-02-14 | ||||||
| 2024-09-30 | -$15.31 10-K · filed 2025-12-29 | -$0.51 10-K · filed 2025-01-13 | ||||||
| 2024-06-30 | -$4.18 10-Q · filed 2025-08-14 | -$12.51 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$0.14 10-Q · filed 2025-05-14 | -$0.28 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | -$0.14 10-Q · filed 2025-02-14 | |||||||
| 2023-09-30 | -$0.73 10-K · filed 2025-01-13 | |||||||
| 2022-12-31 | -$0.18 10-Q · filed 2023-02-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.62 derived: net income ÷ weighted average shares · filed 2023-02-14 | |||||
| 2022-09-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-12-27 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-12-27 | -$0.87 10-K · filed 2022-12-27 | |||||
| 2022-06-30 | -$0.23 10-Q · filed 2022-08-12 | -$0.66 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | -$0.23 10-Q · filed 2022-05-13 | -$0.43 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | -$0.20 10-Q · filed 2023-02-14 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$0.65 derived: net income ÷ weighted average shares · filed 2023-02-14 | |||||
| 2021-09-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2022-12-27 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-12-27 | -$0.90 10-K · filed 2022-12-27 | -$0.93 10-K · filed 2021-12-21 | ||||
| 2021-06-30 | -$0.25 10-Q · filed 2022-08-12 | -$0.74 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.28 10-Q · filed 2022-05-13 | -$0.49 10-Q · filed 2022-05-13 | ||||||
| 2020-12-31 | -$0.21 10-Q · filed 2022-02-11 | -$0.35 derived: net income ÷ weighted average shares · filed 2022-02-11 | -$0.62 derived: net income ÷ weighted average shares · filed 2022-02-11 | |||||
| 2020-09-30 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-12-21 | -$0.41 derived: net income ÷ weighted average shares · filed 2021-12-21 | -$0.82 10-K · filed 2021-12-21 | |||||
| 2020-06-30 | -$0.27 10-Q · filed 2021-08-13 | -$0.69 10-Q · filed 2021-08-13 | ||||||
| 2020-03-31 | -$0.25 10-Q/A · filed 2020-12-30 | -$0.41 10-Q/A · filed 2020-12-30 | ||||||
| 2019-12-31 | -$0.16 10-Q · filed 2021-02-12 | |||||||
| 2019-09-30 | -$0.71 10-K/A · filed 2019-12-23 | |||||||
| 2019-03-31 | -$0.22 10-Q/A · filed 2020-12-30 | -$0.19 10-Q/A · filed 2020-12-30 | -$0.75 derived: net income ÷ weighted average shares · filed 2020-12-30 | -$1.07 derived: net income ÷ weighted average shares · filed 2020-12-30 | ||||
| 2018-12-31 | $0.02 10-Q/A · filed 2020-12-30 | -$0.53 derived: net income ÷ weighted average shares · filed 2020-12-30 | -$0.86 derived: net income ÷ weighted average shares · filed 2020-12-30 | -$1.16 derived: net income ÷ weighted average shares · filed 2020-12-30 | ||||
| 2018-09-30 | -$0.61 derived: net income ÷ weighted average shares · filed 2019-12-23 | -$1.02 derived: net income ÷ weighted average shares · filed 2019-12-23 | -$1.36 derived: net income ÷ weighted average shares · filed 2019-12-23 | -$1.87 10-K/A · filed 2019-12-23 | ||||
| 2018-06-30 | -$0.36 10-Q · filed 2018-08-14 | -$0.67 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$1.17 10-Q · filed 2018-08-14 | -$1.67 derived: net income ÷ weighted average shares · filed 2019-05-14 | ||||
| 2018-03-31 | -$0.31 10-Q · filed 2019-05-14 | -$0.81 10-Q · filed 2019-05-14 | -$1.33 derived: net income ÷ weighted average shares · filed 2019-05-14 | -$1.84 derived: net income ÷ weighted average shares · filed 2019-05-14 | ||||
| 2017-12-31 | -$0.53 10-Q · filed 2019-02-14 | -$1.08 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$1.61 derived: net income ÷ weighted average shares · filed 2019-02-14 | -$2.63 derived: net income ÷ weighted average shares · filed 2019-02-14 | ||||
| 2017-09-30 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-12-19 | -$1.08 derived: net income ÷ weighted average shares · filed 2018-12-19 | -$2.15 derived: net income ÷ weighted average shares · filed 2018-12-19 | -$1.91 10-K · filed 2018-12-19 | ||||
| 2017-06-30 | -$0.53 10-Q · filed 2018-08-14 | -$1.64 derived: net income ÷ weighted average shares · filed 2018-08-14 | -$1.34 10-Q · filed 2018-08-14 | -$1.33 10-Q · filed 2017-08-09 | ||||
| 2017-03-31 | -$1.15 10-Q · filed 2018-05-15 | -$0.78 10-Q · filed 2018-05-15 | -$0.03 10-Q · filed 2017-05-10 | |||||
| 2016-12-31 | $0.32 10-Q · filed 2018-02-12 | $0.01 10-Q · filed 2017-02-09 | ||||||
| 2016-09-30 | -$2.37 10-K · filed 2017-12-29 | -$0.09 10-K · filed 2016-12-15 | ||||||
| 2016-06-30 | -$0.03 10-Q · filed 2016-08-09 | -$2.21 10-Q/A · filed 2017-12-11 | ||||||
| 2016-03-31 | -$1.43 10-Q/A · filed 2017-12-11 | -$0.06 10-Q · filed 2017-05-10 | ||||||
| 2015-12-31 | $0.53 10-Q/A · filed 2017-12-11 | $0.02 10-Q · filed 2016-02-09 | ||||||
| 2015-09-30 | -$2.54 10-K/A · filed 2017-12-11 | -$0.10 10-K · filed 2015-12-11 | -$10.51 10-K/A · filed 2017-12-11 | -$0.42 10-K · filed 2015-12-11 | ||||
| 2015-06-30 | -$1.62 10-K/A · filed 2017-12-11 | -$0.06 10-Q · filed 2015-08-07 | ||||||
| 2015-03-31 | -$4.14 10-K/A · filed 2017-12-11 | -$0.17 10-Q · filed 2015-05-08 | -$0.27 10-Q · filed 2015-05-08 | |||||
| 2014-12-31 | -$3.42 10-K/A · filed 2017-12-11 | -$0.11 10-Q · filed 2015-02-06 | ||||||
| 2014-09-30 | -$0.13 10-K · filed 2015-12-11 | -$12.21 10-K/A · filed 2017-12-11 | -$0.49 10-K · filed 2014-12-23 | |||||
| 2014-06-30 | -$0.11 10-K · filed 2015-12-11 | -$0.38 10-Q · filed 2014-08-08 | ||||||
| 2014-03-31 | -$0.24 10-K · filed 2015-12-11 | -$0.36 10-Q · filed 2015-05-08 | ||||||
| 2013-12-31 | -$0.15 10-K · filed 2015-12-11 | |||||||
| 2013-09-30 | -$0.16 10-K · filed 2014-12-23 | -$0.66 10-K · filed 2015-12-11 | ||||||
| 2013-06-30 | -$0.18 10-K · filed 2014-12-23 | -$0.02 10-Q · filed 2013-08-09 | -$0.50 10-Q · filed 2014-08-08 | -$0.05 10-Q · filed 2013-08-09 | ||||
| 2013-03-31 | -$0.14 10-K · filed 2014-12-23 | -$0.01 10-Q · filed 2013-05-10 | -$0.31 10-Q · filed 2014-05-12 | -$0.03 10-Q · filed 2013-05-10 | ||||
| 2012-12-31 | -$0.18 10-K · filed 2014-12-23 | -$0.02 10-Q · filed 2013-02-08 | ||||||
| 2012-09-30 | -$0.16 10-K · filed 2013-12-27 | -$0.01 10-K · filed 2012-12-14 | -$0.78 10-K · filed 2014-12-23 | -$0.07 10-K · filed 2012-12-14 | ||||
| 2012-06-30 | -$0.16 10-K · filed 2013-12-27 | $0.00 10-Q · filed 2012-08-09 | -$0.06 10-Q · filed 2013-08-09 | |||||
| 2012-03-31 | -$0.41 10-K · filed 2013-12-27 | -$0.04 10-Q · filed 2012-05-10 | -$0.06 10-Q · filed 2013-05-10 | |||||
| 2011-12-31 | -$0.22 10-K · filed 2013-12-27 | -$0.02 10-Q · filed 2012-02-09 | ||||||
| 2011-09-30 | -$0.02 10-K · filed 2012-12-14 | -$1.49 10-K · filed 2013-12-27 | -$0.15 10-K · filed 2011-12-23 | |||||
| 2011-06-30 | -$0.02 10-K · filed 2012-12-14 | -$0.12 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | -$0.09 10-K · filed 2012-12-14 | -$0.10 10-Q · filed 2012-05-10 | ||||||
| 2010-12-31 | -$0.03 10-K · filed 2012-12-14 | |||||||
| 2010-09-30 | -$0.06 10-K · filed 2012-12-14 | |||||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-09 | -$0.02 10-Q · filed 2011-08-09 | ||||||
| 2009-09-30 | -$0.31 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |